For most, taking medication during the day is a part of one’s normal routine.  This medication was prescribed by a trusted physician, and usually taken knowing that the U.S. Food and Drug Administration (“FDA”) has vetted the mediation as safe.  While the FDA may monitor the safety of a particular medication, many times the dangers of a particular drug are concealed by the manufacturers.  As a result, thousands of people are seriously injured from adverse reactions from their prescription drugs.

During the FDA approval process, many of the studies performed which demonstrate the efficacy and safety of a particular drug are, either directly or indirectly, paid for or sponsored by the drug manufacturer.  As such, the manufacturer is able to engineer studies and data most favorable to the drug, which leads to improper and inadequate testing.  In turn, the prescription drug receives its approval and enters the market before the true dangers of the drug have been revealed.

Once a drug enters the market, physicians must rely on the pre-market studies and the package insert to assist in their medical decision making process.  By sending a drug to market without adequate testing and appropriate warnings, prescription drug manufacturers do not allow patients and physicians to make fully informed decisions regarding their healthcare needs.  Patients, therefore, usually make the decision to begin taking a new medication without knowing all the risks associated with their new medication.

If you believe you are experiencing an undisclosed adverse side effect from a new medication, it is important to not only contact your physician, but also an experienced pharmaceutical lawyer to assist you.  Taking on big drug companies can be intimidating; however, having the experienced and knowledgeable lawyers at Daniel & Associates by your side can make the process easier. Our team is experienced in fighting the big pharmaceutical companies and well equipped to guide you through this process.   Let us put our team to work for you today.